Autonomix Medical induces exercise of warrants for $4.9 million gross proceeds

• Autonomix Medical entered a warrant inducement for immediate cash exercise of July 2026 Warrants for 857,462 shares at USD 5.75.
• Gross proceeds expected at about USD 4.9 million, before fees.
• Incentive includes unregistered Series E-1 warrants for 535,913 shares, unregistered Series E-2 warrants for 535,913 shares; exercise price USD 6.25.
• New Warrants exercisable on issuance, expiring five years from issuance; company to file SEC registration for resale shares.
• Closing expected on or about Aug. 26, 2026, subject to customary conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autonomix Medical Inc. published the original content used to generate this news brief on August 24, 2026, and is solely responsible for the information contained therein.